More Investing
View Older Stories View Newer Stories-
TD Cowen upgrades Norfolk Southern and CSX on rising takeover odds
-
Polymarket to expand U.S. access with acquisition of QCEX for $112 million
-
General Motors has 'underappreciated upside potential': Benchmark
-
Target cut to Sell as 'sales may continue to underperform,' says Barclays
-
Oppenheimer starts fintech stock at Buy on strength in BNPL market
-
Truist downgrades Royal Caribbean, says trends are ’decent but normalizing’
-
Trump Media accumulates $2 billion in bitcoin assets; DJT jumps 8%
-
F&F hires Goldman Sachs for potential TaylorMade acquisition
-
DoJ to announce USA vs. GOOGL remedies any day: Here’s what to expect
-
BofA sees U.S. avoiding a recession, the Fed not cutting rates this year
-
What could go wrong in H2? HSBC lists main downside risks
-
Tesla stock: Why BofA says Q2 results likely to be challenged
-
What if the Fed hints at a September rate cut next week?
-
Figma aims to raise up to $1.03 billion in NYSE IPO
-
Union Pacific and Norfolk Southern exploring merger
-
Tesla faces bumpy ride in H2, but real story is autonomy, robots: DB
-
Tesla reportedly puts IT executive in charge of North American sales
-
How Shopify quietly became a payments giant in North America
-
Science Applications (SAIC) awarded $63.8 million DoD contract
-
General Dynamics (GD) secures over $106 million in defense contracts
-
Redwire (RDW) stock ticks up after showcasing military UAS capabilities at Army event
-
Chevron CEO says Hess deal ruling eases uncertainty for oil industry
-
Microsoft stock target raised at BofA into FQ4 results
-
Trump raises tariff demands in EU trade talks to 15-20% - FT
-
Barclays warns: 'Negative summer seasonality' is looming
-
Invesco stock soars after seeking to convert QQQ Trust to open-ended fund
-
Analyst says iPhone demand propped up by pricing, pull-ahead ahead of tariffs
-
Humana stock falls after losing Medicare bonus payment lawsuit
-
From chips to cloud: AI's golden era is just starting, says Wedbush's Ives
-
Jefferies starts Stoke at Buy, sees $1 bln+ opportunity in rare epilepsy drug
-
OpenAI faces $700bn+ TAM by 2030: JPMorgan
-
Abbott upgraded after post-earnings selloff, hardware drag seen temporary
-
Morgan Stanley unpacks Tesla's edge: culture, talent, and strategy
-
Intel shares could squeeze higher during earnings, analyst says
-
HSBC says Apple needs more AI to sell more hardware
-
Could renewed US fiscal stimulus shield markets from rising tariff risk?
-
Sarepta shares tumble after report of patient death in early-stage trial
-
Chevron's $53 billion Hess acquisition cleared after arbitration ruling
-
Fed should cut rates by 25 bps in July, Governor Waller says
-
Johnson Controls (JCI) secures $377.9M contract for automation systems
-
Norfolk Southern gains after WSJ reports Union Pacific explores acquisition deal
-
Tesla picks Liberty General Insurance and Acko as insurance partners in India
-
’Feel the AGI’ - OpenAI launches ChatGPT Agent
-
Trump diagnosed with chronic venous insufficiency, remains healthy
-
GSK stock falls after FDA panel rejects blood cancer drug Blenrep
-
Bernstein on U.S. internet stocks: Will the optimism last?
-
Meta (META) names Connor Hayes as head of Threads - Axios
-
Precision BioSciences gets FDA orphan drug designations for DMD treatment
-
Deutsche Bank backs Visa, Mastercard amid fintech sector slump
-
What’s next for Renault stock after profit warning?
